Literature DB >> 7676535

Inhibitory effects of suramin on androgen-dependent and -independent growth of neonatal mouse seminal vesicles in vitro.

N Tanji1, M Yokoyama, M Takeuchi, N Terada, G R Cunha.   

Abstract

The effects of suramin on the growth of seminal vesicles (SVs) of neonatal mice were investigated in vitro. SVs from 0-day-old male mice were cultured in serum-free chemically defined medium supplemented with 5 alpha-dihydrotestosterone (DHT, 10(-8) M) and insulin (10 micrograms/ml), alone and in combination. Prior to culture, SVs from 0-day-old mice had no epithelial branches. SVs cultured in medium with DHT formed numerous epithelial branches, while epithelial branching did not occur in SVs cultured without DHT. The addition of suramin (0.2 mM) to medium containing DHT inhibited the formation of epithelial branches almost completely. Removal of suramin from the medium on days 2, 4, and 6 of culture initiated the formation of epithelial branches. Suramin (0.2 mM) reversibly decreased 3H-thymidine-labeling indices (3H-LI) of both epithelium and mesenchyme of SVs cultured in medium with DHT plus insulin or DHT alone during 8 days of culture. Suramin also decreased 3H-LI of both epithelium and mesenchyme of SVs cultured in medium with insulin alone. The present study indicates that suramin reversibly inhibits not only androgen-dependent but also androgen-independent growth and ductal branching morphogenesis of neonatal mouse SVs.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7676535     DOI: 10.1007/bf00307943

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  19 in total

1.  Androgen receptor expression in developing male reproductive organs.

Authors:  P S Cooke; P Young; G R Cunha
Journal:  Endocrinology       Date:  1991-06       Impact factor: 4.736

Review 2.  Normal and abnormal development of the male urogenital tract. Role of androgens, mesenchymal-epithelial interactions, and growth factors.

Authors:  G R Cunha; E T Alarid; T Turner; A A Donjacour; E L Boutin; B A Foster
Journal:  J Androl       Date:  1992 Nov-Dec

3.  Inhibition of prostatic tumor cell proliferation by suramin: alterations in TGF alpha-mediated autocrine growth regulation and cell cycle distribution.

Authors:  J H Kim; E R Sherwood; D M Sutkowski; C Lee; J M Kozlowski
Journal:  J Urol       Date:  1991-07       Impact factor: 7.450

4.  A general, fast, and sensitive micromethod for DNA determination application to rat and mouse liver, rat hepatoma, human leukocytes, chicken fibroblasts, and yeast cells.

Authors:  B Fiszer-Szafarz; D Szafarz; A Guevara de Murillo
Journal:  Anal Biochem       Date:  1981-01-01       Impact factor: 3.365

5.  Autocrine transformation by chimeric signal peptide-basic fibroblast growth factor: reversal by suramin.

Authors:  A Yayon; M Klagsbrun
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

6.  Antiproliferative effects of suramin on androgen responsive tumour cells.

Authors:  E M Berns; A L Schuurmans; J Bolt; D J Lamb; J A Foekens; E Mulder
Journal:  Eur J Cancer       Date:  1990-04       Impact factor: 9.162

7.  Role of iron in the proliferation of the established human tumor cell lines U-937 and K-562: effects of suramin and a lipophilic iron chelator (PIH).

Authors:  K Forsbeck; K Bjelkenkrantz; K Nilsson
Journal:  Scand J Haematol       Date:  1986-11

8.  Suramin: an anticancer drug with a unique mechanism of action.

Authors:  C A Stein; R V LaRocca; R Thomas; N McAtee; C E Myers
Journal:  J Clin Oncol       Date:  1989-04       Impact factor: 44.544

9.  Suramin inhibition of growth factor receptor binding and mitogenicity in AKR-2B cells.

Authors:  R J Coffey; E B Leof; G D Shipley; H L Moses
Journal:  J Cell Physiol       Date:  1987-07       Impact factor: 6.384

10.  Suramin inhibits the growth of human rhabdomyosarcoma by interrupting the insulin-like growth factor II autocrine growth loop.

Authors:  C P Minniti; M Maggi; L J Helman
Journal:  Cancer Res       Date:  1992-04-01       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.